Thoroughbred Breeders Queensland Association President Bob Frappell has welcomed the Government funding for research into a Hendra Virus Vaccine.
The Queensland and Federal Governments have committed $300,000 each to the Australian Animal Health Laboratory (AAHL) to trial the effectiveness of a Hendra vaccine in horses.
This funding will allow AAHL to continue the work they have been doing to develop the Hendra virus vaccine.
"I am ecstatic about this progress," said Mr Frappell.
"It's fantastic that the Governments have finally put up the money.
"The Thoroughbred industry should not have had to bear the brunt of this costly research, as Hendra affects all sectors of the equine industry."
Yesterday's announcement follows the latest shock case of Hendra Virus at Tewantin on the Sunshine Coast last week.
But Mr Frappell believes the tireless efforts of Brisbane Equine Veterinary Surgeon, Dr Peter Reid, also played a key role in obtaining the funds.
"I would like to congratulate Dr Reid for his persistence and I think he managed to finally persuade the Queensland Government to take the lead in this issue," stated Mr Frappell.
AAHL have indicated that, it will still take four to five years to fully develop a vaccine to be sold commercially, but a trial vaccine should be available in about two years.
"As the vaccine is still years away - it is important that ongoing research into Hendra virus continues and that we continue to educate people about risk management," said Mr Frappell.
The TBQA website has in depth information on Hendra Virus, following a seminar the Association conducted at UQ Gatton last year.
